| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |